search
Back to results

Mechanical Dilatation of the Cervix at Elective Caesarean Section on Post-operative Morbidity

Primary Purpose

Cesarean Section Complications

Status
Not yet recruiting
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
mechanical cervical dilatation
Sponsored by
Beni-Suef University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Cesarean Section Complications focused on measuring Cesarean Section, Mechanical Dilatation

Eligibility Criteria

20 Years - 40 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria: Elective Cs (primary or repeated CS) Exclusion Criteria: Medical or obstetric conditions that may put them at risk for uterine atony and postpartum hemorrhage and infection, such as: Emergency Cesarean section Chorioamnionitis. Preterm caesarean section. Multiple gestations. Fever during admission. Rupture of membranes. Anemia

Sites / Locations

  • Beni-suef university Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

dilation group

control

Arm Description

mechanical cervical dilatation will be done.

in which no mechanical cervical dilatation will be done.

Outcomes

Primary Outcome Measures

postpartum 6th month scar thickness
measure the thickness of the residual myometrial tissue (RMT) in mm by transvaginal ultrsound

Secondary Outcome Measures

Full Information

First Posted
July 26, 2023
Last Updated
August 15, 2023
Sponsor
Beni-Suef University
search

1. Study Identification

Unique Protocol Identification Number
NCT05997498
Brief Title
Mechanical Dilatation of the Cervix at Elective Caesarean Section on Post-operative Morbidity
Official Title
The Effect of Mechanical Dilatation of the Cervix at Elective Caesarean Section on Post-operative Morbidity
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
August 30, 2023 (Anticipated)
Primary Completion Date
January 30, 2024 (Anticipated)
Study Completion Date
February 20, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Beni-Suef University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The study aims to evaluate the effects of cervical dilatation during cesarean section on postoperative maternal morbidity through different clinical parameters.
Detailed Description
A randomized double-blind clinical trial comparing cervical dilatation during caesarean section to no intervention. Study participants and sample size This study will include pregnant women with a singleton fetus at term ≥37 weeks of gestation and will be scheduled for elective caesarean section. Eligible participants will be allocated either to the study group (women with intraoperative cervical dilatation) or the control group (women with no intraoperative cervical dilatation). Types of interventions Mechanical dilatation of the cervix using a finger, sponge forceps during non-labour caesarean section ***Randomization and Allocation A statistician prepared a computer-generated random tableand placed the group allocation in serially numbered closed opaque envelopes in a 1:1 ratio. Packing, sealing and numbering will be performed by two independent doctors other than the investigator. Patients are allocated to either study group (cervical dilatation) or control group (no cervical dilatation). Allocation will be never changed after opening the envelopes. All patients are blinded to the allocation to avoid bias. **Neither the investigator nor the outcome assessor following up the patient postoperatively are aware whether the patient had undergone cervical dilation during the cesarean section or not (double-blinding). Randomization coding tables will be hidden from the investigator till the end of the study. Group I (dilation group): in which mechanical cervical dilatation will be done. Group II (Non-dilation group): in which no mechanical cervical dilatation will be done. ***** ***Study procedure: After taking informed written consent, the recruited patients will be subjected to the following: Clinical examination: History: personal (age, duration of marriage), present (any current medical or surgical diseases and any current medication), Past (history of any medical disorder) and obstetric history (including Parity, Gestational age, obstetric complications). Indications for cesarean were determined as malposition of the fetal head, head-pelvis incompatibility, disrupted fetal heart rate. General examination: assessment of body mass index (BMI) ,vital data (pulse, blood pressure, temperature), cardiac and chest auscultation to exclude contraindications for anesthesia. Abdominal examination: assessment of fundal level, fetal lie and presentation liquor volume and previous scar if present. Vaginal examination: to exclude cervical changes. Ultrasound examination: to assess fetal viability, determine gestational age and exclude major anomalies. Steps: Informed consent will be obtained from women who will be invited to participate in the research after an explanation of the benefits and risks of this trial. All caesarean sections will be performed by a senior registrar capable of doing uncomplicated elective cesarean sections.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cesarean Section Complications
Keywords
Cesarean Section, Mechanical Dilatation

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Masking Description
A statistician prepared a computer-generated random tableand placed the group allocation in serially numbered closed opaque envelopes in a 1:1 ratio. Packing, sealing and numbering will be performed by two independent doctors other than the investigator. Patients are allocated to either study group (cervical dilatation) or control group (no cervical dilatation). Allocation will be never changed after opening the envelopes. All patients are blinded to the allocation to avoid bias. Neither the investigator nor the outcome assessor following up the patient postoperatively are aware whether the patient had undergone cervical dilation during the cesarean section or not (double-blinding). Randomization coding tables will be hidden from the investigator till the end of the study.
Allocation
Randomized
Enrollment
180 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
dilation group
Arm Type
Experimental
Arm Description
mechanical cervical dilatation will be done.
Arm Title
control
Arm Type
No Intervention
Arm Description
in which no mechanical cervical dilatation will be done.
Intervention Type
Procedure
Intervention Name(s)
mechanical cervical dilatation
Intervention Description
mechanical cervical dilatation during elective cesarean section
Primary Outcome Measure Information:
Title
postpartum 6th month scar thickness
Description
measure the thickness of the residual myometrial tissue (RMT) in mm by transvaginal ultrsound
Time Frame
6 months after delivery

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Elective Cs (primary or repeated CS) Exclusion Criteria: Medical or obstetric conditions that may put them at risk for uterine atony and postpartum hemorrhage and infection, such as: Emergency Cesarean section Chorioamnionitis. Preterm caesarean section. Multiple gestations. Fever during admission. Rupture of membranes. Anemia
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Salem
Phone
01272842226
Ext
02
Email
sara_abdallah100@yahoo.com
Facility Information:
Facility Name
Beni-suef university Hospital
City
Banī Suwayf
State/Province
Beni Suef
ZIP/Postal Code
62521
Country
Egypt

12. IPD Sharing Statement

Plan to Share IPD
Yes

Learn more about this trial

Mechanical Dilatation of the Cervix at Elective Caesarean Section on Post-operative Morbidity

We'll reach out to this number within 24 hrs